AstroNova Earnings Call Transcripts
Fiscal Year 2027
-
Revenue grew 4% year-over-year, led by aerospace, with gross margin up 490 bps to 36.6%. Bookings rose 32.6%, backlog strengthened, and a major settlement removed uncertainty. Positive outlook is supported by strong demand and an upcoming royalty expiration.
Fiscal Year 2026
-
H2 fiscal 2026 saw improved sales momentum, margin expansion, and stronger cash generation, with Product ID and aerospace segments both contributing to growth. Strategic alternatives are under review, and a major royalty expiration in fiscal 2027 will boost gross profit.
-
Transformation efforts drove margin and cash improvements, with Product ID and Aerospace segments both showing strong performance. Full-year guidance is reiterated, and cost reductions plus refinancing have strengthened the balance sheet.
-
Revenue declined year-over-year in both major segments, with a net loss and lower gross profit. New leadership is driving restructuring, cost reductions, and product launches, aiming for improved margins and sales as aircraft build rates rise and operational changes take effect.
-
Q1 FY26 saw 14.4% revenue growth and strong gains in both product ID and aerospace, driven by new product launches and a major defense contract. Cost reductions and margin improvements are expected to continue, with full-year guidance reaffirmed.
Fiscal Year 2025
-
Fiscal 2025 saw revenue and margin declines due to MTEX integration, Boeing strike, and defense order delays, but the aerospace segment achieved record results. Fiscal 2026 guidance anticipates 7.4% revenue growth, margin improvement, and benefits from new product launches and restructuring.
-
Q3 revenue grew 7.7% year-over-year, driven by aerospace, but margins and profits declined due to MTEX integration challenges and higher costs. The company is realigning MTEX, launching cost reductions, and expects full integration by mid-2025, with no near-term guidance provided.
-
Q2 2025 delivered 14.1% revenue growth, led by a strong rebound in Test & Measurement and contributions from the MTEX acquisition, though MTEX integration weighed on margins. Full-year guidance for organic growth is reaffirmed, but EBITDA margin targets are lowered due to integration delays.
-
Q1 revenue declined 7% year-over-year due to temporary supply chain issues, but gross margin improved and profitability was maintained. The MTEX NS acquisition expands market reach and is expected to add $8–$10 million in revenue this year. Integration and transition to higher-margin products are on track.
Fiscal Year 2024
-
The company leverages its data visualization expertise to lead in specialty printing and aerospace solutions, with 70% recurring revenue and a global footprint. Recent acquisitions, notably MTEX, expand its high-end product range and geographic reach, while ongoing innovation and operational integration remain top priorities.
-
Revenue reached $148 million in FY 2024, driven by product innovation, recurring revenue, and strategic acquisitions. Recent supply chain issues have been resolved, and the company targets mid-single digit organic growth and margin expansion for FY 2025. MTEX acquisition strengthens product offerings and geographic reach.